Wilfactin

Wilfactin is a human von Willebrand factor concentrate used to manage bleeding disorders like von Willebrand disease. This intravenous therapy helps replace missing clotting proteins to support normal blood function. It is prescribed for patients with confirmed deficiency or dysfunction of von Willebrand factor. Suitable for adults and children when medically indicated.

Wilfactin is used to prevent and control bleeding episodes in people with von Willebrand disease, a genetic disorder that affects blood clotting. It works by replacing the missing or dysfunctional von Willebrand factor in the blood, which is essential for proper clotting. This medication is often prescribed before medical procedures to reduce bleeding risk. It may also be used to treat heavy menstrual bleeding in affected individuals.

After administration, Wilfactin helps restore normal clotting function by increasing levels of von Willebrand factor in the bloodstream. Users may notice reduced bruising, shorter bleeding times, and improved wound healing. The effects vary depending on the individual’s condition and the dose administered. Regular use may help maintain stable clotting function over time.

Wilfactin should only be used under medical supervision due to the risk of allergic reactions or infusion-related side effects. Patients with known allergies to human blood products should inform their healthcare provider before use. Proper storage and handling are essential to maintain product integrity. Always follow the prescribed administration schedule and report any unusual symptoms immediately.

Wilfactin may interact with medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Combining it with these therapies could increase the risk of bleeding. Patients should inform their doctor about all medications they are taking, including over-the-counter products. Alcohol and certain herbal supplements may also influence clotting function and should be discussed with a healthcare provider.